Primary care and specialist management options

Bailliere's Best Practice and Research in Clinical Rheumatology

Volumn 13, Issue 3, 1999, Pages 469-477

  Schachna, Lionel ^c   Littlejohn, Geoffrey ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH MEDICAL CENTRE   (Australia)

^c NONE

Author keywords

Emotional distress; Fibromyalgia; Interdisciplinary; Management; Primary care; Psychosocial

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; FLUOXETINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; EMOTIONAL STRESS; EXERCISE; EXPECTANCY; FAMILY HISTORY; FIBROMYALGIA; HUMAN; HYPNOSIS; MASSAGE; MEDICAL SPECIALIST; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SELF CARE;

EID: 0033379844     PISSN: 15216942     EISSN: None     Source Type: Journal    
DOI: 10.1053/berh.1999.0037     Document Type: Article

References (52)

1. * 1. Littlejohn GO. A database for fibromyalgia. Rheumatic Disease Clinics of North America 1995; 21: 527-557.
2. Hewett JE, Buckelew SP, Johnson JC et al. Selection of measures suitable for evaluating change in fibromyalgia clinical trials. Journal of Rheumatology 1995; 22: 2307-2312.
3. * 3. Alarcon GS & Bradley LA. Advances in the treatment of fibromyalgia: current status and future directions. American Journal of Medical Sciences 1998; 315: 397-414.
4. Nicassio PM, Schuman C, Kim J et al. Psychosocial factors associated with complementary treatment use in fibromyalgia. Journal of Rheumatology 1997; 24: 2008-2013.
5. Kennedy M & Felson DT. A prospective long-term study of fibromyalgia syndrome. Arthritis and Rheumatism 1996; 39: 682-685.
6. Buskila D, Neumann L, Hazanov I & Carmi R. Familial aggregation in the FM syndrome. Seminars in Arthritis and Rheumatism 1996; 26: 605-611.
7. Alagiri M, Chottiner S, Ratner V et al. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology 1997; 49: 52-57.
8. Robbins JM, Kirmayer LJ & Kapusta MA. Illness worry and disability in fibromyalgia syndrome. International Journal of Psychiatry in Medicine 1990; 20: 49-63.
9. Gladman DD, Urowitz MB, Gough J & MacKinnon A. Fibromyalgia is a major contributor to quality of life in lupus. Journal of Rheumatology 1997; 24: 2145-2148.
10. Littlejohn GO. Fibrositis/fibromyalgia syndrome in the workplace. Rheumatic Disease Clinics of North America 1989; 15: 45-60.
11. Hsu VM, Patella SJ & Sigal LH. 'Chronic Lyme disease' as the incorrect diagnosis in patients with fibromyalgia. Arthritis and Rheumatism 1993; 36: 1493-1500.
12. Wallace AM, Lee J & Dobke MK. Pain after breast surgery: a survey of 282 women. Pain 1996; 66: 195-205.
13. Hudson JI, Goldenberg DL, Pope HG Jr et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. American Journal of Medicine 1992; 92: 362-367.
14. Kurtze N, Gundersen KT & Svebak S. The role of anxiety and depression in fatigue and patterns of pain among subgroups of fibromyalgia patients. British Journal of Medical Psychology 1998; 71: 185-194.
15. Winfield JB. Fibromyalgia: what's next? Arthritis Care and Research 1997; 10: 219-221.
16. *16. Buskila D, Neumann L, Vaisberg G et al. Increased rates of FM following cervical spine injury: a controlled study of 161 cases of traumatic injury. Arthritis and Rheumatism 1997; 40: 446-452.
17. *17. Turk DC, Okifuji A, Starz TW & Freeman TR. Effects of type of type of symptom onset on psychological distress and disability in FM patients. Pain 1996; 68: 423-430.
18. Wolfe F, Smythe HA, Yunus MB et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis and Rheumatism 1990; 33: 160-172.
19. Yunus MB, Inanici F & Aldag JC. Incomplete fibromyalgia syndrome: a clinical and psychological comparison with fibromyalgia. Arthritis and Rheumatism 1998; 41: S258.
20. Sigal LH, Chang DJ & Sloan V. 18 tender points and the '18-wheeler' sign: clues to the diagnosis of fibromyalgia. Journal of the American Medical Association 1998; 279: 434.
21. Tan EM, Feltkamp TE, Smolen JS et al. Range of antinuclear antibodies in 'healthy' individuals. Arthritis and Rheumatism 1997; 40: 1601-1611.
22. Wolfe E. The fibromyalgia problem [editorial]. Journal of Rheumatology 1997; 24: 1247-1249.
23. Hadler NM. Fibromyalgia: La maladie est Morte. Vive le malade! Journal of Rheumatology 1997; 24: 1250-1251.
24. *24. Aaron LA, Bradley LA, Alarcon GA et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behaviour rather than to illness. Arthritis and Rheumatism 1996; 39: 436-445.
25. *25. Aaron LA, Bradley LA, Alarcon GS et al. Perceived physical and emotional trauma as precipitating events in fibromyalgia. Arthritis and Rheumatism 1997; 40: 453-460.
26. *26. MacFarlane GJ, Thomas E, Papageorgio AC et al. The natural history of chronic pain in the community: a better prognosis than in the clinic? Journal of Rheumatology 1996; 23: 1617-1620.
27. *27. McCain GA. A cost-effective approach to the diagnosis and treatment of fibromyalgia. Rheumatic Disease Clinics of North America 1996; 22: 323-349.
28. Demitrack MA. Chronic fatigue syndrome and fibromyalgia: dilemmas in diagnosis and clinical management. Psychiatric Clinics of North America 1998; 21: 571-592.
29. Littlejohn GO. Fibromyalgia syndrome. Medical Journal of Australia 1996; 165: 387-391.
30. McCain GA, Dell DA, Mai FM & Halliday PD. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis and Rheumatism 1988; 31: 1135-1141.
31. 135xenon clearance from exercising muscle. Arthritis and Rheumatism 1989; 32: 454-460.
32. Martin L, Nutting A, MacIntosh BR et al. An exercise program in the treatment of fibromyalgia. Journal of Rheumatology 1996; 23: 1050-1053.
33. Granges G, Zilko P & Littlejohn GO. Fibromyalgia syndrome: assessment of the severity of the condition two years after diagnosis. Journal of Rheumatology 1994; 21: 523-529.
34. Moldofsky H, Scarisbrick P, England R & Smythe H. Musculoskeletal symptoms and non-REM sleep disturbance in patients with 'fibrositis syndrome' and healthy subjects. Psychosomatic Medicine 1975; 37: 341-351.
35. Affleck G, Urrows S, Tennen H et al. Sequential daily relations of sleep, pain intensity and attention to pain among women with FM. Pain 1996; 68: 363-368.
36. May KP, West SG, Baker MR & Everett DW. Sleep apnoea in male patients with the fibromyalgia syndrome. American Journal of Medicine 1993; 94: 505-508.
37. Yunus MB & Aldag JC. Restless leg syndrome and leg cramps in FM syndrome: a controlled study. British Journal of Medicine 1997; 312: 1329-1339.
38. Wolfe F, Anderson J, Harkness D et al. A prospective, longitudinal multicentre study of service utilisation and costs in fibromyalgia. Arthritis and Rheumatism 1997; 40: 1560-1570.
39. Goldenberg D, Mayskiy M, Mossey C et al. A randomised, double-blind crossover trial of fluoxetene and amitriptyline in the treatment of fibromyalgia. Arthritis and Rheumatism 1996; 39: 1852-1859.
40. *40. Godfrey RG. A guide to the understanding and use of tricyclic anti-depressants in the overall management of fibromyalgia and other chronic pain syndromes. Archives of Internal Medicine 1996; 156: 1047-1052.
41. McQuay HJ & Moore RA. Antidepressants and chronic pain. British Journal of Medicine 1997; 314: 763-764.
42. Chambliss ML. Are serotonin uptake inhibitors useful in chronic pain syndromes such as fibromyalgia or diabetic nephropathy? Archives of Family Medicine 1998; 7: 420-421.
43. *43. Alarcon GS & Bradley LA. Advances in the treatment of fibromyalgia: current status and future directions. American Journal of the Medical Sciences 1998; 315: 397-404.
44. Sorensen J, Bengtsson A, Ahlner J et al. Fibromyalgia-are there different mechanisms in the processing of pain? A double blind crossover comparison of analgesic drugs. Journal of Rheumatology 1997; 24: 1615-1621.
45. Ferraccioli G, Ghirelli L, Scita F et al. EMG-biofeedback training in fibromyalgia syndrome. Journal of Rheumatology 1987; 14: 820-825.
46. Haanen HC, Hoenderdos HT, van Romande LK et al. Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. Journal of Rheumatology 1991; 18: 72-75.
47. Vlaeyen JW, Teeken-Gruben NJ, Goossens ME et al. Cognitive-educational treatment of fibromyalgia: a randomised clinical trial: I Clinical effects. Journal of Rheumatology 1996; 23: 1237-1245.
48. Goossens ME, Rutten-van Molken MP, Leidl RM et al. Cognitive-educational treatment of fibromyalgia: a randomised clinical trial: II Economic evaluation. Journal of Rheumatology 1996; 23: 1246-1254.
49. *49. Bennett M. Multidisciplinary group programs to treat fibromyalgia patients. Rheumatic Disease Clinics of North America 1996; 22: 351-367.
50. Bennett RM, Burckhardt CS, Clark SR et al. Group treatment of fibromyalgia: a 6 month outpatient program. Journal of Rheumatology 1996; 23: 521-528.
51. Nicassio PM, Radojevic V, Weisman MH et al. A comparison of behavioural and educational interventions for fibromyalgia. Journal of Rheumatology 1997; 24: 2000-2007.
52. Littlejohn GO. Management of fibromyalgia syndrome. Current Therapeutics 1998; 39: 53-65.